Back
Akari Therapeutics PLC Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
25
AKTX
Akari Therapeutics PLC
Last Price:
2.30
Seasonality Move:
-8%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 2.36 | Sell |
| 50-day SMA: | 2.8 | Sell |
| 200-day SMA: | 2.56 | Sell |
| 8-day EMA: | 2.35 | Sell |
| 20-day EMA: | 2.45 | Sell |
| 50-day EMA: | 2.72 | Sell |
| 200-day EMA: | 3 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 39.49 | Sell |
| Chaikin Money Flow: | -4833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.24 - 2.62) | Sell |
| Bollinger Bands (100): | (2.62 - 3.7) | Sell |
Akari Therapeutics PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 2.24 while AKTX 8-day simple moving average is 2.36, which is a Sell signal.
- The stock price of AKTX is 2.24 while Akari Therapeutics PLC 20-day SMA is 2.36, which makes it a Sell.
- Akari Therapeutics PLC 50-day simple moving average is 2.80 while AKTX share price is 2.24, making it a Sell technically.
- AKTX stock price is 2.24 and Akari Therapeutics PLC 200-day simple moving average is 2.56, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
25
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Sell
The current Akari Therapeutics PLC [AKTX] share price is $2.24. The Score for AKTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
26.78M
Price in USD:
2.24
Share Volume:
5.52K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
1.08
Sell
25
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?
The Akari Therapeutics PLC stock price is 2.24 USD today. -
Will AKTX stock go up or go down?
Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Akari Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 2.24 while AKTX 8-day exponential moving average is 2.35, which is a Sell signal.
- The stock price of AKTX is 2.24 while Akari Therapeutics PLC 20-day EMA is 2.45, which makes it a Sell.
- Akari Therapeutics PLC 50-day exponential moving average is 2.72 while AKTX share price is 2.24, making it a Sell technically.
- AKTX stock price is 2.24 and Akari Therapeutics PLC 200-day simple moving average is 3.00, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
- AKTX Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Akari Therapeutics PLC is a Sell
- Akari Therapeutics PLC Relative Strength Index (RSI) is 39.49, which suggest Akari Therapeutics PLC is oversold
- The Bollinger Bands (25) for Akari Therapeutics PLC is (2.24 - 2.62), which suggest Akari Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Akari Therapeutics PLC is (2.62 - 3.7), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.